Navigation Links
CryoPort Creates Personal Wall on Wallst.net's Financial Social Community, my.wallst.net
Date:4/15/2008

NEW YORK, April 15 /PRNewswire-FirstCall/ -- CryoPort, Inc. (OTC Bulletin Board: CYRX) (http://www.CryoPort.com) will be updating the investment community through their personal profile on MyWallst.net available at http://www.wallst.net. The dynamic profile will include interviews with company representatives, on which investors can comment, and links to recent press.

Visit CryoPort's profile on Mywallst.net at http://my.wallst.net/profile.php?ID=19849.

Stay updated about CryoPort, Inc., post a comment on their personal page, join CryoPort's message board to discuss company activity with other interested parties, "invest" in OTCBB: CYRX through the Rookie Challenge and join his financial social network today.

About WallSt.net:

http://www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. (http://www.financialmediagroupinc.com). The Web site is a leading provider of timely business news, executive interviews, multimedia content, and research tools. Financial Media Group, Inc. also owns http://my.wallst.net, a financial social network for investors, and Financial Filings Corp. (http://www.financialfilings.com), a provider of compliance solutions to publicly traded companies. We have received nine hundred ninety five dollars from CryoPort, Inc. for media and advertising services. In addition to WallSt.net, WallStreet Direct, Inc. owns and operates WallStRadio (http://www.wallstradio.com), a business and finance podcast Web site.

About CryoPort, Inc.:

CryoPort develops leading edge, proprietary, technology-driven shipping and storage products for use in the rapidly growing global biotechnology and biopharmaceutical cold chain. The products developed by CryoPort are essential components of the infrastructure required for the testing, research and end user delivery of temperature-sensitive medicines and biomaterials in an increasingly complex logistical environment. The Company offers a complete end to end shipping solution with its products for pharmaceutical clinical trials, gene biotechnology, transport of infectious materials and dangerous goods and pharmaceutical distribution. It markets its services directly in the Americas, Europe, and Asia. The company was founded in 1999.

Contact: CryoPort, Inc.

Investor Relations

Stuart Fine

908-469-1788


'/>"/>
SOURCE CryoPort, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ADVENTRX Creates Executive Vice President Position and Announces New Chief Financial Officer
2. MIT creates gecko-inspired bandage
3. Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U.S.
4. Digital Unions RT1(TM) Software Creates Telegenetics Network for Region 3 Genetics Collaborative
5. U.S. Preventive Medicine and deCODE Genetics Sign Letter of Intent to Expand Personalized Medicine Platform
6. Seduce with Mousse - Replens Introduces Intimate Options: First Personal Lubricant Mousse in Canada
7. WaferGen to Present at the Cambridge Health Institutes Fifth Annual Molecular Diagnostics Partnerships in Personalized Medicine Conference
8. Center for Molecular Medicine Partners with AviaraDx to Offer New Cancer Tests to Aid Physicians in Personalizing Treatment
9. Siemens and National Jewish Medical and Research Center Form Strategic Alliance to Advance Shared Vision of Personalized Medicine
10. Statement by John Bailey, Chief Scientist: The Personal Care Products Council Response to Study on Phthalate Exposure in Baby Care Products
11. AMDLs First Full Service JPGreen Health and Personal Care Center Set to Open in Hangzhou, China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... manufacturing company, today announced several positive developments that position the Company for the ... result of the transaction, Craig F. Kinghorn has been appointed Chairman of the ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... ... Michael Fitzmaurice recently became double board-certified in surgery and surgery of the hand ... Dr. Fitzmaurice is no stranger to going above and beyond in his pursuit ...
(Date:5/25/2016)... ... May 25, 2016 , ... Biohaven Pharmaceutical Holding ... has granted the company’s orphan drug designation request covering BHV-4157 for the treatment ... by the FDA. , Spinocerebellar ataxia is a rare, debilitating neurodegenerative disorder ...
(Date:5/23/2016)... ... ... need for blood donations in South Texas and across the nation is growing. , But ... blood donations are on the decline. In fact, donations across the country are at their ... Texas in the last four years alone. , There is no substitute for blood. , ...
Breaking Biology Technology:
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):